SCHEMBL21822136

SCHEMBL21822136

O=S(=O)(c1ccccc1)c1cc(CO)c2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.47
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NAMPT P43490 2/20 0.38
ACP3 P15309 1/20 0.38
PIK3CA P42336 1/20 0.37
PIK3C3 Q8NEB9 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21822208 0.85 HTR6 (0.45) HTR6L3MBTL1KDM4EALDH1A1NAMPT
SCHEMBL25016119 0.81 HTR6 (0.41) HTR6L3MBTL1TDP1ALDH1A1POLB
SCHEMBL21822152 0.78 IL1RN (0.50) MEN1KMT2AALDH1A1CYP2C19HSD17B10
SCHEMBL1062435 0.77 HTR6 (0.48) HTR6L3MBTL1MEN1KMT2AKDM4E
SCHEMBL9818489 0.76 HTR6 (0.50) HTR6KDM4EALDH1A1HPGDCYP2C19
SCHEMBL3080680 0.73 HTR6 (0.49) HTR6ALDH1A1POLB
SCHEMBL21822300 0.71 KDM4E (0.50) TDP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL1332008 0.71 HTR6 (0.82) HTR6TDP1ALDH1A1HSD17B10POLB
(Phenylsulfonyl)Benzene SCHEMBL28237512 0.71 HTR6 (0.93) HTR6L3MBTL1TDP1MEN1KMT2A
SCHEMBL13147952 0.70 CYP1A2 (0.44) HTR6L3MBTL1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 US disclosed
EP-3860636-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF Disc Medicine, Inc. (US) 2021-08-11 EP disclosed
CN-112996529-A Matriptase 2 inhibitor and application thereof 迪斯克医药公司 2021-06-18 CN disclosed
WO-2020072580-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. (US) 2020-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 HTR6 830/4885L3MBTL1 1147/4885TDP1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.